Literature DB >> 2655627

Alzheimer's disease.

B T Hyman1, H Damasio, A R Damasio, G W Van Hoesen.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2655627     DOI： 10.1146/annurev.pu.10.050189.000555

Source DB:  PubMed          Journal:  Annu Rev Public Health        ISSN： 0163-7525            Impact factor:   21.981


× No keyword cloud information.
  13 in total

Review 1.  Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.

Authors:  Dharmini C Mehta; Jennifer L Short; Sarah N Hilmer; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

2.  Diffusion and perfusion MR imaging in cases of Alzheimer's disease: correlations with cortical atrophy and lesion load.

Authors:  A Bozzao; R Floris; M E Baviera; A Apruzzese; G Simonetti
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

3.  Testosterone modifies the effect of APOE genotype on hippocampal volume in middle-aged men.

Authors:  M S Panizzon; R Hauger; A M Dale; L J Eaves; L T Eyler; B Fischl; C Fennema-Notestine; C E Franz; M D Grant; A J Jak; K C Jacobson; M J Lyons; S P Mendoza; M C Neale; E C Prom-Wormley; L J Seidman; M T Tsuang; H Xian; W S Kremen
Journal:  Neurology       Date:  2010-09-07       Impact factor: 9.910

4.  Disturbed neurotransmitter transporter expression in Alzheimer's disease brain.

Authors:  Kevin H Chen; Edmund A Reese; Hyung-Wook Kim; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 5.  Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders.

Authors:  Kristi A Sacco; Katie L Bannon; Tony P George
Journal:  J Psychopharmacol       Date:  2004-12       Impact factor: 4.153

6.  Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer's disease: a proof of concept study.

Authors:  Jonathan Bentwich; Evgenia Dobronevsky; Sergio Aichenbaum; Ran Shorer; Ruth Peretz; Michael Khaigrekht; Revital Gandelman Marton; Jose M Rabey
Journal:  J Neural Transm (Vienna)       Date:  2011-01-19       Impact factor: 3.575

7.  Disruption of leptin signalling in a mouse model of Alzheimer's disease.

Authors:  Anna King; Anna Brain; Kelsey Hanson; Justin Dittmann; James Vickers; Carmen Fernandez-Martos
Journal:  Metab Brain Dis       Date:  2018-03-15       Impact factor: 3.584

8.  Evidence for Alzheimer's disease-linked synapse loss and compensation in mouse and human hippocampal CA1 pyramidal neurons.

Authors:  Krystina M Neuman; Elizabeth Molina-Campos; Timothy F Musial; Andrea L Price; Kwang-Jin Oh; Malerie L Wolke; Eric W Buss; Stephen W Scheff; Elliott J Mufson; Daniel A Nicholson
Journal:  Brain Struct Funct       Date:  2014-07-17       Impact factor: 3.270

9.  Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model.

Authors:  Juhyun Song; Bo Eun Hur; Kiran Kumar Bokara; Wonsuk Yang; Hyun Jin Cho; Kyung Ah Park; Won Taek Lee; Kyoung Min Lee; Jong Eun Lee
Journal:  Yonsei Med J       Date:  2014-04-01       Impact factor: 2.759

10.  The Density of Group I mGlu5 Receptors Is Reduced along the Neuronal Surface of Hippocampal Cells in a Mouse Model of Alzheimer's Disease.

Authors:  Alejandro Martín-Belmonte; Carolina Aguado; Rocío Alfaro-Ruiz; José Luis Albasanz; Mairena Martín; Ana Esther Moreno-Martínez; Yugo Fukazawa; Rafael Luján
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.